4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001415889-24-002378
Options or other derivatives
- CEO AND CHIEF MEDICAL OFFICER acquired 1,500,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Thye Dirk CEO AND CHIEF MEDICAL OFFICER | 2024-02-01 | Grant or award · Employee Stock Option (right to buy) | +1,500,000 | 1,500,000 | D | ||
Loading xslF345X05/form4-02022024_100215.xml…